Wendy Putnam

Examiner
DISC Type : cs

Vice President, Clinical Pharmacology & DMPK at Ultragenyx

Belmont, California, United States

Overview

Wendy Putnam is the Vice President of Clinical Pharmacology & DMPK at Ultragenyx, specializing in drug development for rare diseases. Her expertise covers biotherapeutics and small molecules. She holds a PhD from the University of California, San Francisco and a BS from The Johns Hopkins University.

Her posts frequently highlight opportunities to join her team, emphasizing a collaborative and impactful work environment. She appears passionate about recruiting top talent to help advance therapies for patients with rare diseases.

Wendy previously served as the Pharmacology Team Leader for the asthma drug Lebrikizumab while at Genentech.

Personality Overview

Tough To Convince

Unexpressive

Status Quo Seeker

They tend to have clarity about their needs and constraints, and are unlikely to over-promise.  They are heavily focused on quality and prefer doing things the right way, even if it takes time. They are always well-planned and adopt a systematic approach.

Topics They Care About

Rare Disease Therapies
Her role at Ultragenyx and her social media posts are centered on advancing innovative therapies for patients with rare and ultra-rare diseases.
Clinical Pharmacology
As a VP in this field, her career is dedicated to clinical pharmacology, nonclinical and clinical PKPD, and global regulatory interactions.
Drug Development
She has extensive experience leading the development of a diverse pipeline of therapeutic modalities, including biologics, gene therapies, and small molecules.

Media Appearances

Wendy has no verified media appearances

Work History

2-2024
Vice President, Clinical Pharmacology & DMPK at Ultragenyx
9-2020 - 3-2024
Executive Director, Clinical Pharmacology & DMPK at Ultragenyx
3-2019 - 9-2020
Director & Principal Scientist, Clinical Pharmacology at Genentech
10-2017 - 3-2019
Associate Director & Principal Scientist, Clinical Pharmacology at Genentech
6-2011 - 8-2018
Pharmacology Team Leader, Lebrikizumab at Genentech

Education

1997 - 2002
PhD from University of California, San Francisco
BS from The Johns Hopkins University

More Information

Social Presence :

Prographics :

Exp : 18 Location : Belmont, California, United States Job Level : Senior Designation : Vice President, Clinical Pharmacology & DMPK at Ultragenyx
URL has been copied!

Insights For Selling To Wendy

During A Call Or A Meeting

DO's

  • First of all, focus on building their confidence by sharing examples, case studies etc.
  • Ask them which other stakeholders would be important for this purchase decision
  • Expect them to be slow and cautious, encourage them to ask more questions

DONT's

  • Don't be very accepting if that is your natural style, stay firm
  • Don't rely on relationship building even if they act pleasantly
  • Don't push them too hard to make fast decisions, give them time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Wendy is

  • Proof of usage by others in the industry, case studies showing ROI are likely to work the best with them.
  • Will you ever get a clear answer from Wendy

  • They don’t say no often, they push out the decisions or keep going around in circles.

Insights For Deal Planning

    How fast (or slow) will Wendy move?

  • They are some of the slowest movers and take their time reaching decisions.
  • Can Wendy take some risk or not?

  • They have very low acceptance of risk even if they do not say it directly.

You And Wendy

Personality Compatibility


Other Ultragenyx Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.